KRT19 and biliary tract disorder: CYFRA21–1, a soluble fragment of CK19 and a useful marker for non-small cell lung cancer (NSCLC) (18), has been gaining attention for its potential role in the diagnosis and prognosis of liver and biliary tract diseases (33, 34).